TRIM66 and Monogenic Olfactory Receptor Expression

2026-09-17

The reference study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence excess olfactory receptor genes and stabilize one-neuron-one-receptor expression. Genetic, expression, chromatin, neural-activity, and behavioral evidence connects this regulatory step to olfactory information processing, while also clarifying why receptor derepression does not necessarily produce stronger sensory signaling.

Soluble PD-L1 in Glioma: Wnt/β-Catenin Control

2026-09-17

The reference study identifies glioma cells as a source of soluble PD-L1 and links its production to Wnt/β-catenin signaling, providing a mechanistic explanation for impaired CD8+ T-cell activity. Its findings support plasma sPD-L1 as a potentially useful prognostic readout and suggest that combined Wnt and PD-L1 inhibition may improve antitumor activity.

Tumor-Targeted Engineering Reinvigorates T Cells

2026-09-16

Fusobacterium EVs Enable Colorectal Tumor Adhesion

2026-09-16

Zheng et al. identify Fusobacterium nucleatum extracellular vesicles as active niche-conditioning agents in colorectal cancer, rather than passive bacterial products. The study shows that these vesicles fuse with colorectal cancer cells, transfer the bacterial surface protein FomA, and create a tumor-cell surface that favors subsequent bacterial adhesion and colonization.

MCC950 sodium in Endothelial Pyroptosis

2026-09-15

MCC950 sodium, also known as CRID3 sodium salt, gives researchers a selective way to test whether NLRP3 signaling links oxidative stress to endothelial pyroptosis. This workflow adapts an HUVEC injury model into a practical assay for inflammatory disease research while preserving controls for cell viability, cytokine release, and endothelial function.

Tacrolimus (FK506): From Calcineurin to Translation

2026-09-15

A translational roadmap for using Tacrolimus (FK506) as a precise calcineurin probe while accounting for cytokine biology, metabolic stress, assay design, and preclinical relevance.

FGF19-ELF4 Signaling Drives Colorectal Cancer Metastasis

2026-09-14

The reference study identifies ELF4 as a clinically relevant transcriptional driver linking FGF19 signaling to colorectal cancer metastasis through coordinated activation of FGFR4 and SRC. Its combination of patient profiling, functional metastasis assays, transcriptomics, chromatin studies, and pharmacological inhibition provides a mechanistic framework for evaluating this pathway in metastatic disease.

TAK-242 Workflows for TLR4 Inflammation Research

2026-09-14

TAK-242 (Resatorvid) gives researchers reversible pharmacological control over TLR4-driven inflammation, from macrophage cytokine assays to endotoxemia-associated extracellular vesicle and coagulation studies. This workflow-focused guide connects dose selection, timing, controls, and troubleshooting with practical neuroinflammation research applications.

Primidone B2120: Reliable Cell Assay Design

2026-09-13

Learn how Primidone (SKU B2120) can support mechanism-led cell viability, proliferation, and cytotoxicity workflows through defined TRPM3 and RIPK1 concentration ranges. This scenario-based guide covers solvent handling, dose selection, interpretation, translational boundaries, and practical supplier evaluation.

ATRX Loss Sensitizes Glioma Cells to RTK Inhibitors

2026-09-12

The reference study identifies a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells are more sensitive to several multi-targeted receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient cells. Its drug-screening and combination data support incorporating ATRX status into interpretation of RTK inhibitor trials and into preclinical temozolomide combination studies.

4-Phenylbutyric Acid for ER Stress Workflows

2026-09-11

Use 4-PBA as a mechanistic rescue tool, not merely an ER stress marker, to test whether stress signaling drives apoptosis or cytotoxic autophagy. This workflow translates liver cancer findings into practical dosing, controls, endpoint selection, and troubleshooting strategies.

Preserving Protein Signals in Atopic Dermatitis Research

2026-09-11

Translational atopic dermatitis research depends on more than an effective formulation: it also requires sample preparation that preserves the molecular evidence behind therapeutic decisions. This article connects melatonin-loaded sacchachitin nanofiber hydrogel research with a practical, EDTA-free strategy for protecting proteins during extraction, Western blotting, co-immunoprecipitation, and phosphorylation analysis.

Recombinant Mouse Sonic Hedgehog Workflow

2026-09-10

Use Recombinant Mouse Sonic Hedgehog to connect controlled dose-response assays with ex vivo developmental models. This workflow combines alkaline phosphatase benchmarking, genital-tubercle culture, cross-species comparisons, and practical troubleshooting for congenital malformation research.

nPEC for Dual-Loaded Liposome Encapsulation

2026-09-10

The reference study compares separation workflows for measuring encapsulation efficiency when liposomes contain hydrophilic and lipophilic drugs together. It identifies nanoparticle exclusion chromatography coupled with online HPLC as the most broadly applicable approach among the tested methods, including for oleanolic acid and doxorubicin hydrochloride co-loaded liposomes.

12-O-tetradecanoyl phorbol-13-acetate (TPA) Workflows

2026-09-09

Build time-resolved PKC and ERK/MAPK experiments with 12-O-tetradecanoyl phorbol-13-acetate (TPA), from biochemical kinase assays to neuronal injury and skin cancer models. This practical guide connects pathway activation with mitochondrial, autophagy, viability, and tumor-promotion readouts while emphasizing controls and troubleshooting.